Kosuke Muto

Has grant

National Cerebral and Cardiovascular Center
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

The 38th Kato Memorial International Exchange Grant (Second-Half Program)

Open Date: 2026-10-01

Close Date: 2026-11-01

Grant: Close

FY2026 Overseas Travel Support Program for Students of the Graduate School of Medical Sciences

Open Date: 2026-08-01

Close Date: 2026-08-01

Articles (9)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background The Impella CP is a widely used mechanical circulatory support device for patients with cardiogenic shock undergoing high‐risk percutaneous coronary intervention. Hemostasis following Impella removal remains a clinical challenge. Although the preclosure technique using the Perclose ProGlide device is standard in elective procedures, its feasibility in emergency settings for cardiogenic shock has not been well established. Methods This single‐center, retrospective study included 14 consecutive patients with myocardial infarction complicated by cardiogenic shock who underwent Impella CP insertion between January 2020 and December 2024. Patients requiring coronary artery bypass grafting or venoarterial extracorporeal membrane oxygenation were excluded. A single Perclose ProGlide device was deployed using the preclosure technique at the time of Impella insertion. For hemodynamically stable patients, the Impella was removed within 48 h at the bedside. Procedural endpoints comprised door‐to‐preclose, door‐to‐unloading (DTU), and door‐to‐balloon (DTB) times. Safety endpoints were also evaluated. Results 10 patients underwent Impella removal using the preclosure technique, and 4 patients underwent surgical cutdown. Comparing the preclose and surgical groups, the DTU time was not significantly different (median [interquartile range]: 89.5 [86.25–98.75] min vs. 92.0 [74.5–112.5] min, respectively; p = 0.811), nor was the DTB time (107.0 [104.25–119.75] min vs. 109.0 [88.5–131.0] min, respectively; p = 1.000). However, the time to Impella removal was significantly shorter in the preclose versus surgical groups (25.0 [22.0–27.75] h vs. 73.0 [59.0–91.5] h, respectively; p = 0.014). Technical success was achieved in all cases without major bleeding, surgical conversion, or infection. Conclusions This study demonstrated the feasibility and safety of total percutaneous bedside Impella CP removal using a single Perclose ProGlide device in patients with cardiogenic shock. The preclosure technique did not prolong DTB or DTU times and may be a practical alternative to surgical Impella device removal in stable patients.

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Coronary stent fractures (SFs) are an emerging complication of coronary stents. There are numerous risk factors for SF, which include vessel angulation, use of sirolimus‐eluting stent (SES), long stents, multiple stent layers, stent overlap, inflammation, hypersensitivity, stenting in the right coronary artery, heavy calcification, ostial bifurcational lesions, and stent overexpansion. There have been reports of SF in BES (Nobori) in past studies, but no reports on BES (Biofreedom) have been documented yet. SF increases the risk of in‐stent restenosis, stent thrombosis (ST), target lesion revascularization and major adverse cardiac events. A coronary artery aneurysm (CAA) is a rare complication of SF. Although the risk of CAA rupture with SF is high, the treatment and management of CAA with SF remain unclear. Here, we report the case of a 72‐year‐old man who had SF of a BES (Biofreedom) complicated with a micro‐CAA and review some of the literature.

Year:

2025

Collaborators (2)

Ritsushi Kato

-

JAPAN
View details

Satoshi Honda

National Cerebral and Cardiovascular Center

JAPAN
View details